ClinicalTrials.govpublic full text
Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?
covid19, bio-adrenomedullin, point of care, sepsis, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828158
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.